We found that treatment of both tumor models resulted in a consistent and significant modulation of genes in the vicinity of MED1 and CDK8-associated super-enhancers identified from ChIP-seq datasets (Figure 4B–C and Figure 4—source data 1). This evidence concerns the gene CDK8 and neoplasm.